tradingkey.logo
tradingkey.logo
Buscar

Xtant Medical Holdings Inc

XTNT
Añadir a la lista de seguimiento
0.440USD
+0.020+4.76%
Horarios del mercado ETCotizaciones retrasadas 15 min
61.62MCap. mercado
33.43P/E TTM

Más Datos de Xtant Medical Holdings Inc Compañía

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Información de Xtant Medical Holdings Inc

Símbolo de cotizaciónXTNT
Nombre de la empresaXtant Medical Holdings Inc
Fecha de salida a bolsaJun 30, 2010
Director ejecutivoBrowne (Sean E)
Número de empleados217
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 30
Dirección664 Cruiser Lane
CiudadBELGRADE
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal59714
Teléfono14063880480
Sitio Webhttps://xtantmedical.com/
Símbolo de cotizaciónXTNT
Fecha de salida a bolsaJun 30, 2010
Director ejecutivoBrowne (Sean E)

Ejecutivos de Xtant Medical Holdings Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
--
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
--
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
+0.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
--
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
--
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
+0.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Xtant Medical Holdings Inc?

Los cinco principales accionistas de Xtant Medical Holdings Inc son: Mr. Stavros G. Vizirgianakis

¿Cuál es la mayor fuente de ganancias de Xtant Medical Holdings Inc?

El 2026Q4, el segmento empresarial Orthobiologics generó la ganancia más alta para Xtant Medical Holdings Inc, ascendiendo a 72.89M y representando el 54.43% de la ganancia total.